These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 15588423

  • 1. Mechanisms of TLR9 activation.
    Latz E, Visintin A, Espevik T, Golenbock DT.
    J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB.
    Proc Natl Acad Sci U S A; 2001 Jul 31; 98(16):9237-42. PubMed ID: 11470918
    [Abstract] [Full Text] [Related]

  • 8. The immunophysiological impact of bacterial CpG DNA on the gut.
    Watson JL, McKay DM.
    Clin Chim Acta; 2006 Feb 31; 364(1-2):1-11. PubMed ID: 16153626
    [Abstract] [Full Text] [Related]

  • 9. CpG DNA: security code for host defense.
    Medzhitov R.
    Nat Immunol; 2001 Jan 31; 2(1):15-6. PubMed ID: 11135571
    [No Abstract] [Full Text] [Related]

  • 10. Toll-like receptors involved in the response to microbial pathogens: development of agonists for toll-like receptor 9.
    Schetter C, Vollmer J.
    Curr Opin Drug Discov Devel; 2004 Mar 31; 7(2):204-10. PubMed ID: 15603254
    [Abstract] [Full Text] [Related]

  • 11. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M, Lee LN, Evans GF, Zuckerman SH.
    J Immunol Methods; 2005 May 10; 300(1-2):93-9. PubMed ID: 15894327
    [Abstract] [Full Text] [Related]

  • 16. TLR9 and the recognition of self and non-self nucleic acids.
    Lamphier MS, Sirois CM, Verma A, Golenbock DT, Latz E.
    Ann N Y Acad Sci; 2006 Oct 10; 1082():31-43. PubMed ID: 17145922
    [Abstract] [Full Text] [Related]

  • 17. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM, Al-Khairy D, Ingalls RR.
    Biol Reprod; 2006 May 10; 74(5):824-31. PubMed ID: 16421230
    [Abstract] [Full Text] [Related]

  • 18. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
    Latz E, Verma A, Visintin A, Gong M, Sirois CM, Klein DC, Monks BG, McKnight CJ, Lamphier MS, Duprex WP, Espevik T, Golenbock DT.
    Nat Immunol; 2007 Jul 10; 8(7):772-9. PubMed ID: 17572678
    [Abstract] [Full Text] [Related]

  • 19. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
    Saitoh S, Miyake K.
    Immunol Rev; 2009 Jan 10; 227(1):32-43. PubMed ID: 19120473
    [Abstract] [Full Text] [Related]

  • 20. Cathepsins are required for Toll-like receptor 9 responses.
    Matsumoto F, Saitoh S, Fukui R, Kobayashi T, Tanimura N, Konno K, Kusumoto Y, Akashi-Takamura S, Miyake K.
    Biochem Biophys Res Commun; 2008 Mar 14; 367(3):693-9. PubMed ID: 18166152
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.